CAR T cell therapy is a promising form of treatment for cancer, and now Ragon Institute investigator Todd Allen, PhD, recently published findings suggesting dual CAR T cell therapy could be an option for HIV.
CAR T cell therapy is a promising form of treatment for cancer, and now Ragon Institute investigator Todd Allen, PhD, recently published findings suggesting dual CAR T cell therapy could be an option for HIV.
A unique platform developed in anticipation of a rapidly spreading infectious disease like COVID-19 is now being put into action to develop a vaccine.
Mass General researchers have made a key discovery about how the cellular process of autophagy can extend or shorten lifespan.
The second annual Mass General Research Institute LAB DAY gave friends and supporters of Mass General research an up-close look at science.
To understand more about infant immunity and how to enhance it, a research team led by Galit Alter, PhD investigated how certain antibodies are transferred from mother to child during pregnancy.
Mass General researchers have created a new zebrafish model that could vastly improve our ability to model cancer growth and test new treatments.
Researchers at the Center for Genomic Medicine have become pivotal players in the emergence of precision medicine due to their various roles as local and international leaders in genomics.
Some people wake up early like clockwork with a chipper attitude and are eager to start the day. Then there those who have a bit of a slower start, but stay up till the wee hours claiming they’re most productive at night. Sound familiar? It turns out those waking habits may be embedded in our genes,Read more
Researchers from Mass General have found a connection between immune cells and metabolism that could contribute diseases such as obesity, diabetes and more.
Researchers at Massachusetts General Hospital are using advanced brain imaging techniques to learn more about how brain disorders function at a molecular and genetic level.
Copyright 2024 | Mass General Research Institute | Disclaimer